Dollar General vs. Dollar Tree: Which Discount Stock Wins the Value Game?
Dollar General struggled with macro headwinds over the past few years.
Dollar Tree's divestment of Family Dollar could represent a fresh start.
The pricier stock could actually be the better value.
10 stocks we like better than Dollar General ›
Dollar General (NYSE: DG) and Dollar Tree (NASDAQ: DLTR), the two largest dollar stores in America, both survived the retail apocalypse which wiped out many other retailers over the past decade. They kept opening new stores even as other retailers pulled back, and they countered Amazon and Walmart by selling cheaper products.
That resilience made them reliable recession-resistant investments. But over the past three years, Dollar General's stock plunged more than 50% as Dollar Tree's stock dropped over 30%. Let's see why these two stocks sank -- and if either one is a better value play right now.
The differences between Dollar General and Dollar Tree
Dollar General mainly opens its stores in rural areas which haven't been saturated by superstores. It doesn't actually sell everything for a dollar, but it tries to sell its products at much lower prices than its competitors. It generates most of its revenue in the U.S., but it expanded into Mexico with its Mi Súper Dollar General stores in 2022.
From fiscal 2021 and fiscal 2024 (which ended Jan. 31, 2025), Dollar General's number of year-end stores increased from 18,130 to 20,594. For fiscal 2025, it plans to open approximately 575 new stores in the U.S. and up to 15 new stores in Mexico.
Dollar Tree focuses on urban and suburban markets, and it tries to wedge its stores between lower income neighborhoods and superstores like Walmart. It originally sold all of its products for $1, but it raised its prices over the past four years to counter inflation and sell a broader range of products. It acquired its chief competitor Family Dollar in 2015, but it finally sold the struggling banner after a decade of sluggish sales this year.
From fiscal 2021 to fiscal 2024 (which ended Feb. 1, 2025), Dollar Tree's number of year-end stores (including Family Dollar) grew from 15,115 to 16,774. But in fiscal 2025, its store count will decline as it divests its Family Dollar stores. At the end of the first quarter of 2025, its Dollar Tree segment operated 9,016 stores.
What challenges do the dollar stores face?
Dollar General and Dollar Tree both grew their same-store sales over the past three years.
Data source: Company earnings reports. *Excluding Family Dollar.
Dollar General's same-store sales slowed in fiscal 2023 as it grappled with inflationary headwinds for consumer spending (especially among lower income consumers), theft and inventory shrinkage issues, and cost-cutting measures, which caused operational challenges.
But in fiscal 2024, its growth accelerated again as it closed some weaker stores, prioritized operational improvements over immediate cost-cutting strategies, and opened more Popshelf concept stores to sell a broader range of higher-margin, non-essential goods.
For fiscal 2025, it expects its same-store sales to rise 1.5% to 2.5% as it continues to open more Popshelf stores, adds gas stations to more of its rural Dollar General stores, remodels its older locations, and continues to open new stores in more promising markets. It expects its diluted EPS, which plunged 32% in fiscal 2024, to rise 2% to 14% in fiscal 2025. Analysts expect its EPS to grow 12% for the year, even as the unpredictable tariffs squeeze its near-term margins.
Dollar Tree's same-store sales growth decelerated in fiscal 2023 and 2024 as it grappled with inflation, weak consumer spending, bloated inventories, and theft. Its decision to broaden its price range alienated some of its customers, and its "combo strategy" of merging some of its Dollar Tree and Family Dollar banners didn't halt that slowdown.
But for fiscal 2025, Dollar Tree sees its same-store sales rising 3% to 5%. It expects that acceleration to be driven by its ongoing conversion of its stores to its newer multi-price "3.0 format" (with $1.25-$7.00 tiers) to attract higher income customers. The divestment of Family Dollar should also free up more cash to strengthen its main banner.
Dollar Tree expects adjusted EPS from continuing operations, which dipped 12% in fiscal 2024, to rise 1% to 11% in fiscal 2025. Analysts expect its adjusted EPS to grow 6%.
Which dollar store stock is the better value right now?
Dollar General trades at 20 times forward earnings and pays a forward dividend yield of 2.2%. Dollar Tree trades at 21 times forward earnings but doesn't pay a dividend.
Dollar General might be the cheaper stock, but I think Dollar Tree's divestment of Family Dollar, its stronger same-store sales growth, and it's clearer plans for broadening its reach among higher-income consumers make it the more compelling investment. Dollar General's focus on rural areas limits its ability to attract more affluent customers, while its expansion of Popshelf could run into a lot of competition from similar retailers like Five Below.
Should you invest $1,000 in Dollar General right now?
Before you buy stock in Dollar General, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Dollar General wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!*
Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 28, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
a minute ago
- Globe and Mail
Is Disney About to Beat Netflix in Streaming?
Disney 's (NYSE: DIS) recent earnings report, including deals with the NFL and WWE, signal a big shift toward becoming a streaming giant. The company's potential to generate more streaming revenue than Netflix after ESPN's streaming app launches could help Disney stock. *Stock prices used were end-of-day prices of Aug. 6, 2025. The video was published on Aug. 6, 2025. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,026%* — a market-crushing outperformance compared to 180% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 4, 2025 Travis Hoium has positions in Walt Disney. The Motley Fool has positions in and recommends Apple, Netflix, and Walt Disney. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
National Post
a minute ago
- National Post
Cresco Labs Solid Q2 Performance and Debt Refinancing Strengthen Foundation for Long-Term Value Creation
Article content CHICAGO — Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (' Cresco Labs ' or the ' Company '), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the second quarter ended June 30, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here. Article content Second Quarter 2025 Highlights Article content Second quarter revenue of $164 million. Second quarter operating cash flow of $9 million. Gross profit of $83 million. Adjusted gross profit 1 of $83 million; and an Adjusted gross margin 1 of 50.6% of revenue. SG&A of $51 million or 31.4% of revenue. Net loss of $14 million, includes non-cash impairment charges of $9 million related to California assets being considered held for sale. Second quarter Adjusted EBITDA 1 of $41 million and Adjusted EBITDA margin 1 of 25.0%. Retained the No. 1 share position in multiple billion dollar markets. 2 Article content Management Commentary Article content 'In Q2, we delivered solid performance in line with guidance, maintained our market share in a highly competitive environment, and continued to drive cash flow through operational discipline. Crucially, we signed a commitment letter to refinance our debt with a new $325 million term loan. This milestone reinforces our balance sheet, preserves our equity value and creates financial flexibility for years to come. The improved structure and terms give us a stronger foundation to execute against both near-term priorities and long-term growth opportunities.' Article content 'The cannabis industry is entering a new phase, defined by consolidation and rationalization. We're seeing more opportunities for M&A in very productive states that will be incremental for Cresco. As previously stated, we're going to be opportunistic while staying patient and disciplined so we can invest in sustainable growth when the right opportunities arise. With our proven operating model, focused and productive footprint, and clean capital structure, we're built for this moment and are well-positioned to be a partner of choice as the industry consolidates.' Article content Balance Sheet, Liquidity, and Other Financial Information Article content As of June 30, 2025, current assets were $315 million, including cash and cash equivalents of $147 million. The Company had senior secured term loan debt, net of discount and issuance costs, of $354 million and a mortgage loan, net of discount and issuance costs of $18 million. Total shares on a fully converted basis to Subordinate Voting Shares were 483,444,948 as of June 30, 2025. Article content 1 See 'Non-GAAP Financial Measures' at the end of this press release for more information regarding the Company's use of non-GAAP financial measures. 2 According to Hoodie Analytics. Article content Conference Call and Webcast Article content The Company will host a conference call and webcast to discuss its financial results on Thursday, August 7, 2025, at 8:30am Eastern Time (7:30am Central Time). The conference call may be accessed via webcast or by dialing 1-833-470-1428 (US Toll Free) or 1-404-975-4839 (US Local), providing access code 158138. Archived access to the webcast will be available for one year on Cresco Labs' investor website, here. Article content Consolidated Financial Statements Article content The financial information reported in this press release is based on unaudited management prepared financial statements for the quarter ended June 30, 2025. These financial statements have been prepared in accordance with U.S. GAAP. The Company expects to file its unaudited condensed interim consolidated financial statements for the quarter ended June 30, 2025, on SEDAR+ and EDGAR on or about August 7, 2025. Accordingly, such financial information may be subject to change. All financial information contained in this press release is qualified in its entirety with reference to such financial statements. While the Company does not expect there to be any material changes between the information contained in this press release and the consolidated financial statements it files on SEDAR+ and EDGAR, to the extent that the financial information contained in this press release is inconsistent with the information contained in the Company's financial statements, the financial information contained in this press release shall be deemed to be modified or superseded by the Company's filed financial statements. The making of a modifying or superseding statement shall not be deemed an admission, for any purposes, that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws. Further, the reader should refer to the additional disclosures in the Company's audited financial statements for the year ended December 31, 2024, filed on SEDAR+ and EDGAR. Article content Cresco Labs references certain non-GAAP financial measures throughout this press release, which may not be comparable to similar measures presented by other issuers. Please see the 'Non-GAAP Financial Measures' section below for more detailed information. Article content Non-GAAP Financial Measures Article content This release reports its financial results in accordance with U.S. GAAP and includes certain non-GAAP financial measures that do not have standardized definitions under U.S. GAAP. The non-GAAP measures include: Earnings before interest, taxes, depreciation, and amortization ('EBITDA'); Adjusted EBITDA; Adjusted EBITDA margin; Adjusted gross profit; Adjusted gross profit margin; Adjusted selling, general, and administrative expenses ('Adjusted SG&A'), Adjusted SG&A margin; and Free Cash Flow are non-GAAP financial measures and do not have standardized definitions under U.S. GAAP. The Company defines these non-GAAP financial measures as follows: EBITDA as net loss (income) before interest, taxes, depreciation, and amortization; Adjusted EBITDA as EBITDA less other (expense) income, net, fair value mark-up for acquired inventory, adjustments for acquisition and non-core costs, impairment and share-based compensation; Adjusted EBITDA Margin as Adjusted EBITDA divided by revenues, net; Adjusted gross profit as gross profit less fair value mark-up for acquired inventory and adjustments for acquisition and non-core costs; Adjusted gross profit margin as Adjusted gross profit divided by revenues, net; Adjusted SG&A as SG&A less adjustments for acquisition and non-core costs; Adjusted SG&A margin as Adjusted SG&A divided by revenues, net; and Free Cash Flow as Net cash provided by operating activities less purchases of property and equipment and proceeds from tenant improvement allowances. The Company has provided the non-GAAP financial measures, which are not calculated or presented in accordance with U.S. GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with U.S. GAAP and may not be comparable to similar measures presented by other issuers. These supplemental non-GAAP financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should only be considered in conjunction with, the U.S. GAAP financial measures presented herein. Accordingly, the Company has included below reconciliations of the supplemental non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with U.S. GAAP. Article content About Cresco Labs Inc. Article content Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production, and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's, and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development, and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs' journey by visiting or following the Company on Facebook, X or LinkedIn. Article content Forward-Looking Statements Article content This press release contains 'forward-looking information' within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute 'forward-looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995 (collectively, 'forward-looking statements'). Such forward-looking statements are not representative of historical facts or information or current condition but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as, 'may,' 'will,' 'should,' 'could,' 'would,' 'expects,' 'plans,' 'anticipates,' 'believes,' 'estimates,' 'projects,' 'predicts,' 'potential,' or 'continue,' or the negative of those forms or other comparable terms. The Company's forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under 'Risk Factors' in the Company's Annual Information Form for the year ended December 31, 2024, filed on SEDAR+ and EDGAR, other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company's forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs' shares, nor as to the Company's financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company's forward-looking statements contained herein, whether as a result of new information, any future event, or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise. Article content Cresco Labs Inc. For the Three Months Ended June 30, 2025, March 31, 2025, and June 30, 2024 For the Three Months Ended ($ in thousands) June 30, 2025 March 31, 2025 June 30, 2024 Revenue, net $ 163,624 165,757 184,356 Cost of goods sold 80,368 87,126 89,578 Gross profit 83,256 78,631 94,778 Gross profit % 50.9 % 47.4 % 51.4 % Operating expenses: Selling, general, and administrative 51,398 57,811 54,355 Share-based compensation 2,032 2,075 2,854 Depreciation and amortization 4,420 5,156 5,189 Impairment loss 9,265 — — Total operating expenses 67,115 65,042 62,398 Income from operations 16,141 13,589 32,380 Other (expense) income, net: Interest expense, net (12,562 ) (14,824 ) (13,813 ) Other (expense) income, net (836 ) 317 (59,508 ) Total other expense, net (13,398 ) (14,507 ) (73,321 ) Income (loss) before income taxes 2,743 (918 ) (40,941 ) Income tax expense (16,636 ) (14,316 ) (10,238 ) 1 Net loss includes amounts attributable to non-controlling interests. Article content Cresco Labs Inc. Summarized Consolidated Statements of Financial Position As of June 30, 2025 and December 31, 2024 ($ in thousands) June 30, 2025 December 31, 2024 (unaudited) Cash and cash equivalents $ 146,609 $ 137,564 Other current assets 167,996 156,693 Property and equipment, net 332,600 344,846 Intangible assets, net 289,268 293,994 Goodwill 283,484 283,484 Other non-current assets 127,802 138,774 Total assets $ 1,347,759 $ 1,355,355 Total current liabilities $ 101,324 $ 94,338 Total non-current liabilities 885,523 872,841 Total shareholders' equity 360,912 388,176 Total liabilities and shareholders' equity $ 1,347,759 $ 1,355,355 Article content Cresco Labs Inc. Unaudited Reconciliation of Net Loss to Adjusted EBITDA (Non-GAAP) For the Three Months Ended June 30, 2025, March 31, 2025, and June 30, 2024 For the Three Months Ended ($ in thousands) June 30, 2025 March 31, 2025 June 30, 2024 Net loss 1 $ (13,893 ) $ (15,234 ) $ (51,179 ) Depreciation and amortization 12,190 12,906 14,930 Interest expense, net 12,562 14,824 13,813 Income tax expense 16,636 14,316 10,238 EBITDA (Non-GAAP) $ 27,495 $ 26,812 $ (12,198 ) Other expense (income), net 836 (317 ) 59,508 Adjustments for acquisition and other non-core costs 734 7,015 3,129 Impairment loss 9,265 — — Share-based compensation 2,546 2,723 3,471 Adjusted EBITDA (Non-GAAP) $ 40,876 $ 36,233 $ 53,910 Adjusted EBITDA % (Non-GAAP) 25.0 % 21.9 % 29.2 % 1 Net loss includes amounts attributable to non-controlling interests. Article content Article content Article content Article content Article content Contacts Article content Media Article content Article content Press@ Article content Investors Article content Article content TJ Cole, Cresco Labs Article content Article content SVP, Corporate Development & Investor Relations Article content Article content investors@ Article content Article content Article content Article content
CTV News
a minute ago
- CTV News
Trump's broad tariffs go into effect, just as economic pain is surfacing
A customer shops a grain isle at New India Bazar, where most merchandise is imported from India and Canada, on Wednesday, Aug. 6, 2025, in Fremont, Calif. (AP Photo/Noah Berger) WASHINGTON — U.S. President Donald Trump began levying higher import taxes on dozens of countries Thursday, just as the economic fallout of his monthslong tariff threats has begun to create visible damage for the U.S. economy. Just after midnight, goods from more than 60 countries and the European Union became subject to tariff rates of 10 per cent or higher. Products from the EU, Japan and South Korea are taxed at 15 per cent, while imports from Taiwan, Vietnam and Bangladesh are taxed at 20 per cent. Trump also expects the EU, Japan and South Korea to invest hundreds of billions of dollars in the U.S. 'I think the growth is going to be unprecedented,' Trump said Wednesday afternoon. He added that the U.S. was 'taking in hundreds of billions of dollars in tariffs,' but he couldn't provide a specific figure for revenues because 'we don't even know what the final number is' regarding tariff rates. Despite the uncertainty, the Trump White House is confident that the onset of his broad tariffs will provide clarity about the path of the world's largest economy. Now that companies understand the direction the U.S. is headed, the administration believes they can ramp up new investments and jump-start hiring in ways that can rebalance the U.S. economy as a manufacturing power. But so far, there are signs of self-inflicted wounds to America as companies and consumers alike brace for the impact of new taxes. What the data has shown is a U.S. economy that changed in April with Trump's initial rollout of tariffs, an event that led to market drama, a negotiating period and Trump's ultimate decision to start his universal tariffs on Thursday. Risk of economic erosion Economic reports show that hiring began to stall, inflationary pressures crept upward and home values in key markets started to decline after April, said John Silvia, CEO of Dynamic Economic Strategy. 'A less productive economy requires fewer workers,' Silvia said in an analysis note. 'But there is more, the higher tariff prices lower workers' real wages. The economy has become less productive, and firms cannot pay the same real wages as before. Actions have consequences.' Even then, the ultimate transformations of the tariffs are unknown and could play out over months, if not years. Many economists say the risk is that the American economy is steadily eroded rather than collapsing instantly. 'We all want it to be made for television where it's this explosion — it's not like that,' said Brad Jensen, a professor at Georgetown University. 'It's going to be fine sand in the gears and slow things down.' Trump has promoted the tariffs as a way to reduce the persistent trade deficit. But importers sought to avoid the taxes by importing more goods before the taxes went into effect. As a result, the US$582.7 billion trade imbalance for the first half of the year was 38 per cent higher than in 2024. Total construction spending has dropped 2.9 per cent over the past year. Dismay in India and Switzerland The lead-up to Thursday fit the slapdash nature of Trump's tariffs, which have been variously rolled out, walked back, delayed, increased, imposed by letter and frantically renegotiated. The process has been so muddled that officials for key trade partners were unclear at the start of the week whether the tariffs would begin Thursday or Friday. The language of the July 31 order to delay the start of tariffs from Aug. 1 only said the higher tax rates would start in seven days. Trump on Wednesday announced additional 25 per cent tariffs to be imposed on India for its buying of Russian oil, bringing its total import taxes to 50 per cent. A top body of Indian exporters said Thursday the latest U.S. tariffs will impact nearly 55 per cent of the country's outbound shipments to America and force exporters to lose their long-standing clients. 'Absorbing this sudden cost escalation is simply not viable. Margins are already thin,' S.C. Ralhan, president of the Federation of Indian Export Organizations, said in a statement. The Swiss executive branch, the Federal Council, was expected to hold an extraordinary meeting Thursday afternoon after President Karin Keller-Sutter and other top Swiss officials returned from a hastily arranged trip to Washington in a failed bid to avert steep 39 per cent U.S. tariffs on Swiss goods. Import taxes are still coming on pharmaceutical drugs and Trump announced 100 per cent tariffs on computer chips. That could leave the U.S. economy in a place of suspended animation as it awaits the impact. Stock market remains solid The president's use of a 1977 law to declare an economic emergency to impose the tariffs is also under challenge. The impending ruling from last week's hearing before a U.S. appeals court could cause Trump to find other legal justifications if judges say he exceeded his authority. Even people who worked with Trump during his first term are skeptical that things will go smoothly for the economy, such as Paul Ryan, the former Republican House speaker, who has emerged as a Trump critic. 'There's no sort of rationale for this other than the president wanting to raise tariffs based upon his whims, his opinions,' Ryan told CNBC on Wednesday. 'I think choppy waters are ahead because I think they're going to have some legal challenges.' Still, the stock market has been solid during the recent tariff drama, with the S&P 500 index climbing more than 25 per cent from its April low. The market's rebound and the income tax cuts in Trump's tax and spending measures signed into law on July 4 have given the White House confidence that economic growth is bound to accelerate in the coming months. As of now, Trump still foresees an economic boom while the rest of the world and American voters wait nervously. 'There's one person who can afford to be cavalier about the uncertainty that he's creating, and that's Donald Trump,' said Rachel West, a senior fellow at The Century Foundation who worked in the Biden White House on labor policy. 'The rest of Americans are already paying the price for that uncertainty.' Josh Boak, The Associated Press
